IL6 and Arthritis: The value of achieving rapid and broad suppression of pro-inflammatory pathways during the earliest phase of arthritis by blocking TNF or IL-6-mediated signalling has been demonstrated, for example leading to sustained remission in about a third of patients [34,35].